Trade Summary

5 days ago, Fox Christine, serving as EVP, U.S. Commercial at Teva Pharmaceutical Industries Ltd (TEVA), sold 21,258 shares at $35.31 per share, for a total transaction value of $750,620.00. Following this transaction, Fox Christine now holds 63,647 shares of TEVA.

This sale represents a 25.00% decrease in Fox Christine's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 30, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 4, 2026, 4 days after the trade was made.

Teva Pharmaceutical Industries Ltd operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.